European Radiology

, Volume 18, Issue 10, pp 2120–2131 | Cite as

Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects

  • Hisanobu KoyamaEmail author
  • Yoshiharu Ohno
  • Atsushi Kono
  • Daisuke Takenaka
  • Yoshimasa Maniwa
  • Yoshihiro Nishimura
  • Chiho Ohbayashi
  • Kazuro Sugimura


This study aimed at prospectively compared efficacy of non-contrast-enhanced (non-CE) MRI and MDCT for management of pulmonary nodules. A total of 161 patients with 200 nodules underwent MDCT and non-CE MRI (T1WI, T2WI, and STIR) in conjunction with pathological and/or more than 2 years of follow-up examinations. To compare qualitative detection rates between both modalities, all nodules were visually assessed. To compare quantitative and qualitative diagnostic capabilities of MRI, calculation of contrast ratio and visual assessment of probability for malignancy in each nodule were performed. Then, detection rate and diagnostic capability were statistically compared. Although the overall detection rate of each MR sequence (82.5%) was significantly lower than that of MDCT (97.0%, p < 0.05), that of malignant nodules showed no significant difference (p > 0.05). The diagnostic capability of STIR was significantly higher than those of other MR sequences (p < 0.05). Non-CE MR imaging was found to be as useful as MDCT for management of pulmonary nodules.


Lung MR CT Primary neoplasm Screening 



The authors thanks Munenobu Nogami, M.D., Ph.D. (Division of PET, Institute of Biomedical Research and Innovation), Yoshikazu Kotani, M.D. (Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine), Masahiro Yoshimura, M.D. (Division of Pulmonary Surgery, Hyogo Cancer Center), Takanori Higashino, M.D., Ph.D. (Department of Radiology, Tenri Hospital), Hideaki Kawamitsu, B.S., and Masahiko Fujii, M.D. (Division of Radiology, Kobe University Hospital) for their contribution to this work. This work was supported by Philips Medical Systems.


  1. 1.
    Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99–105PubMedCrossRefGoogle Scholar
  2. 2.
    Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL (2005) CT screening for lung cancer: 5-year prospective experience. Radiology 235:259–265PubMedCrossRefGoogle Scholar
  3. 3.
    Garg K, Keith RL, Byers T, Kelly K, Kerzner AL, Lynch DA, Miller YE (2002) Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology 225:506–510PubMedCrossRefGoogle Scholar
  4. 4.
    MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF Jr, Swensen SJ, Fleischner Society (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 23:395–400CrossRefGoogle Scholar
  5. 5.
    Swensen SJ (2002) CT screening for lung cancer. AJR Am J Roentgenol 179:833–836PubMedGoogle Scholar
  6. 6.
    Kim JH, Kim HJ, Lee KH, Kim KH, Lee HL (2004) Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 28:766–775PubMedCrossRefGoogle Scholar
  7. 7.
    Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K (2002) Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 224:503–511PubMedCrossRefGoogle Scholar
  8. 8.
    Swensen SJ, Viggiano RW, Midthun DE, Müller NL, Sherrick A, Yamashita K, Naidich DP, Patz EF, Hartman TE, Muhm JR, Weaver AL (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73–80PubMedGoogle Scholar
  9. 9.
    Marom EM, Sarvis S, Herndon JE 2nd, Patz EF Jr (2002) T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 223:453–459PubMedCrossRefGoogle Scholar
  10. 10.
    Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C (2007) Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214–220PubMedGoogle Scholar
  11. 11.
    Jeong YJ, Lee KS, Jeong SY, Chung MJ, Shim SS, Kim H, Kwon OJ, Kim S (2005) Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 237:675–683PubMedCrossRefGoogle Scholar
  12. 12.
    Kono R, Fujimoto K, Terasaki H, Müller NL, Kato S, Sadohara J, Hayabuchi N, Takamori S (2007) Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol 188:26–36PubMedCrossRefGoogle Scholar
  13. 13.
    Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K (2006) Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 47:426–431PubMedGoogle Scholar
  14. 14.
    Vogt FM, Herborn CU, Hunold P, Lauenstein TC, Schröder T, Debatin JF, Barkhausen J (2004) HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 183:71–78PubMedGoogle Scholar
  15. 15.
    Schroeder T, Ruehm SG, Debatin JF, Ladd ME, Barkhausen J, Goehde SC (2005) Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. AJR Am J Roentgenol 185:979–984PubMedCrossRefGoogle Scholar
  16. 16.
    Ohno Y, Sugimura K, Hatabu H (2002) MR imaging of lung cancer. Eur J Radiol 44:172–181PubMedCrossRefGoogle Scholar
  17. 17.
    Both M, Schultze J, Reuter M, Bewig B, Hubner R, Bobis I, Noth R, Heller M, Biederer J (2005) Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. Eur J Radiol 53:478–488PubMedCrossRefGoogle Scholar
  18. 18.
    Kersjes W, Mayer E, Buchenroth M, Schunk K, Fouda N, Cagil H (1997) Diagnosis of pulmonary metastases with turbo-SE MR imaging. Eur Radiol 7:1190–1194PubMedCrossRefGoogle Scholar
  19. 19.
    Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C, Yoshimura M, Satouchi M, Nishimura Y, Sugimura K (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872–879PubMedCrossRefGoogle Scholar
  20. 20.
    Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, Yucel EK, Patriquin L, Eustace S (2000) Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11:343–350PubMedCrossRefGoogle Scholar
  21. 21.
    Yi CA, Jeon TY, Lee KS, Lee JH, Seo JB, Kim YK, Chung MJ (2007) 3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. AJR Am J Roentgenol 18:386–392CrossRefGoogle Scholar
  22. 22.
    Bruegel M, Gaa J, Woertler K, Ganter C, Waldt S, Hillerer C, Rummeny EJ (2007) MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging 25:73–81PubMedCrossRefGoogle Scholar
  23. 23.
    Romano PS, Mark DH (1992) Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 101:1332–1337PubMedCrossRefGoogle Scholar
  24. 24.
    Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, Fry WA, Butz RO, Goldberg M, Waters PF et al (1983) Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86:654–658PubMedGoogle Scholar
  25. 25.
    Nagasaki F, Flehinger BJ, Martini N (1982) Complications of surgery in the treatment of carcinoma of the lung. Chest 82:25–29PubMedCrossRefGoogle Scholar
  26. 26.
    Wiener JI, Chako AC, Merten CW, Gross S, Coffey EL, Stein HL (1986) Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology 160:299–305PubMedGoogle Scholar
  27. 27.
    Fossel ET, Brodsky G, deLayre JL, Wilson RE (1983) Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes. Ann Surg 198:541–545PubMedCrossRefGoogle Scholar
  28. 28.
    Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G (1987) A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med Phys 14:1–37PubMedCrossRefGoogle Scholar
  29. 29.
    Shuman WP, Baron RL, Peters MJ, Tazioli PK (1989) Comparison of STIR and spin-echo MR imaging at 1.5 T in 90 lesions of the chest, liver, and pelvis. AJR Am J Roentgenol 152(4):853–859PubMedGoogle Scholar
  30. 30.
    Fink C, Puderbach M, Biederer J, Fabel M, Dietrich O, Kauczor HU, Reiser MF, Schönberg SO (2007) Lung MRI at 1.5 and 3 Tesla: observer preference study and lesion contrast using five different pulse sequences. Invest Radiol 42(6):377–383PubMedCrossRefGoogle Scholar
  31. 31.
    Obuchowski NA, Graham RJ, Baker ME, Powell KA (2001) Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers. AJR Am J Roentgenol 176:1357–1362PubMedGoogle Scholar
  32. 32.
    Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med 328:1237–1243PubMedCrossRefGoogle Scholar
  33. 33.
    Black WC, Welch HG (1997) Screening for disease. AJR Am J Roentgenol 168:3–11PubMedGoogle Scholar

Copyright information

© European Society of Radiology 2008

Authors and Affiliations

  • Hisanobu Koyama
    • 1
    Email author
  • Yoshiharu Ohno
    • 1
  • Atsushi Kono
    • 1
  • Daisuke Takenaka
    • 1
  • Yoshimasa Maniwa
    • 2
  • Yoshihiro Nishimura
    • 3
  • Chiho Ohbayashi
    • 4
  • Kazuro Sugimura
    • 1
  1. 1.Department of RadiologyKobe University Graduate School of MedicineChuo-kuKobeJapan
  2. 2.Division of Cardiovascular, Thoracic and Pediatric SurgeryKobe University Graduate School of MedicineKobeJapan
  3. 3.Division of Cardiovascular and Respiratory Medicine, Department of Internal MedicineKobe University Graduate School of MedicineKobeJapan
  4. 4.Division of PathologyHyogo Cancer CenterTokyoJapan

Personalised recommendations